Skip to main content

Table 5 Diagnostic accuracy of MTV and ASP towards IR (TG/TL)

From: Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma

 

TG/TL 1

TG/TL 2

TG/TL 3

Parameter

Sens. (95%-CI)

Spec. (95%-CI)

Sens. (95%-CI)

Spec. (95%-CI)

Sens. (95%-CI)

Spec. (95%-CI)

NPV (95%-CI)

PPV (95%-CI)

NPV (95%-CI)

PPV (95%-CI)

NPV (95%-CI)

PPV (95%-CI)

MTV

100% (54 to 100%)

83% (36 to 100%)

80% (44 to 97%)

71% (29 to 96%)

75% (43 to 95%)

89% (52 to 100%)

100% (48 to 100%)

86% (42 to 100%)

71% (29 to 96%)

80% (44 to 97%)

73% (39 to 94%)

90% (55 to 100%)

ASP

83% (36 to 100%)

67% (22 to 96%)

80% (44 to 97%)

43% (10 to 82%)

58% (28 to 85%)

78% (40 to 97%)

80% (28 to 99%)

71% (29 to 96%)

60% (15 to 95%)

67% (35 to 90%)

58% (28 to 85%)

78% (40 to 97%)

  1. TG/TL treatment group/level, Sens. sensitivity, 95%-CI 95%-confidence interval, spec. Specificity, NPV negative predictive value, PPV positive predictive value, MTV metabolic tumor volume, ASP asphericity